Ocular Therapeutix Inc. buy klostergang
Start price
24.06.17
/
50%
€9.34
Target price
06.10.17
€18.04
Performance (%)
-39.77%
End price
06.10.17
€5.63
Summary
This prediction ended on 06.10.17 with a price of €5.63. Massive losses of -39.77% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocular Therapeutix Inc. | 12.353% | 12.353% | -9.393% | 140.554% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by klostergang for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
klostergang stimmt der Buy-Einschätzung von tamam zu
klostergang stimmt am 24.06.2017 der Buy-Einschätzung von tamam mit dem Kursziel 20$ zu.Überschrift: Ocur looks significantly undervalued,
(Vom Mitglied beendet)